SGN — Solgenics Cashflow Statement
0.000.00%
Last trade - 00:00UtilitiesHighly SpeculativeMicro Cap
- £1.08m
- £5.33m
Annual cashflow statement for Solgenics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.7 | -3.48 | -2.3 | -2.81 | -1.71 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.69 | 1.98 | 0.932 | 1.2 | 0.196 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.02 | 0.004 | 0.101 | 0.06 | -0.149 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.907 | -1.43 | -1.2 | -1.32 | -1.42 |
| Capital Expenditures | -0.051 | -0.032 | -0.058 | -0.187 | -0.169 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.133 | 0.047 | -0.769 | -0.384 | 0 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0.082 | 0.015 | -0.827 | -0.571 | -0.169 |
| Financing Cash Flow Items | -0.05 | -0.084 | -0.213 | -0.138 | 1.25 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.29 | 1.23 | 2.32 | 2.02 | 1.64 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.462 | -0.19 | 0.298 | 0.131 | 0.047 |